Skip to main content

Holocene Advisors, LP

Position in ALKS — Alkermes plc.

CIK 1700574 New York, NY

Position in ALKS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$81,940,647
+$7,869,747 QoQ
Shares Held
2,317,326
-6.1% QoQ
Ownership
1.39%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
14 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ALKS Over Time

Shares Held

Position Value (USD)

Derivatives in ALKS

reported options exposure · as of Jun 30, 2021
CallValue
$12,014,800
CallShares
490,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Holocene Advisors, LP holds $100,418,965 across 4 Drug Manufacturers - Specialty & Generic names. ALKS ranks #1 (81.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALKS
Alkermes plc.
This page
2,317,326 $81,940,647

All Filings in ALKS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $81,940,647 2,317,326
2025-09-30 $74,070,900 2,469,030
2025-06-30 $81,646,302 2,853,768
2025-03-31 $71,805,358 2,174,602
2024-12-31 $7,417,290 257,903
2023-06-30 $39,217,428 1,252,953
2023-03-31 $77,864,980 2,762,149
2022-12-31 $69,024,380 2,641,576
2022-09-30 $54,421,269 2,437,137
2022-06-30 $58,254,553 1,955,507
2022-03-31 $67,709,416 2,573,524
2021-12-31 $68,961,061 2,964,792
2021-09-30 $78,795,459 2,554,976
2021-06-30 $54,115,566 2,206,997
2021-06-30 $12,014,800 490,000